Insider trade

CONMED Corporation (CNMD): CFO sold ~$151K

Todd W Garner, CFO at CONMED Corporation, sold ~$151K of CONMED Corporation shares.

~$151K
Approx. value · 3,500 sh @ $43.00
1,836
Holds after · shares reported
Traded
Nov 6, 2025
Filed
Nov 7, 2025

What stands out in this filing

  • The sale was 65.6% of the shares this insider held before it; the filing reports 1,836 shares afterwards.
  • 3,500 shares at an average of $43.00 each, as reported on the form.
  • Filing box checked: sold under a Rule 10b5-1 plan.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

The company's last weighty Form 8-K report up to this date: reported its results, 1 day earlier (Nov 5, 2025). The first one after it: changed a top executive or board member, 61 days later (Jan 6, 2026).

  1. Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 8, 2025, the Board of Directors (the “Board”) of CONMED Corporation (the “Company”) appointed Kim Kelderman as a director effective immediately. Mr. Kelderman was appointed to the Corporate Governance and Nominating Committee and the Strategy Committee.”
  2. Insider · 1 personInsiders: 2 sales (~$107K)
  3. Company filing · Form 8-K · ResultsReported its results
  4. InsiderCFO sold ~$151K of CNMD shares in the open market

What came next

  1. InsiderOfficer sold ~$11K of CNMD shares in the open market
  2. Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 8, 2026, CONMED Corporation (the “ Company ”) announced the separation of Mr. Todd Garner, the Company’s Chief Financial Officer (“ CFO ”), effective on the earlier of March 15, 2026 or the date on which the Company appoints a new permanent CFO (the “ CFO Transition Date ”).”
  3. Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for CONMED Corporation

For CONMED Corporation, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CNMD page.

Other recent filings by Todd W Garner, Executive Vice President & CFO

The full history of Todd W Garner, Executive Vice President & CFO is on the profile page.

How this filing works

Explore the data

Common questions

Which CONMED Corporation (CNMD) insider traded, and how much?

Todd W Garner, CFO at CONMED Corporation, sold ~$151K of CONMED Corporation shares. 3,500 shares at $43.00.

When did it happen, and when was it made public?

Traded: Nov 6, 2025. Filed: Nov 7, 2025. That is 1 day between the two dates.

What stands out in this filing?

The sale was 65.6% of the shares this insider held before it; the filing reports 1,836 shares afterwards. 3,500 shares at an average of $43.00 each, as reported on the form. Filing box checked: sold under a Rule 10b5-1 plan.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about CONMED Corporation recently?

For CONMED Corporation, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the CNMD page.

Does this mean CNMD stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at CONMED Corporation

Everything OQRO holds on this company is on its CNMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data